Replies to post #430291 on NorthWest Biotherapeutics Inc (NWBO)

[HappyLibrarian]

Very optimistic but after looking at NVCR's timeline today, we still have a long ways to go for all the regulatory approvals, insurance reimbursement negotiations, healthcare adoption, manufacturing capacity, etc. 2022 I see as a transformational year but stock appreciation might lag what we think to be the FMV.

Already we are seeing the lowering of expectations even before 2022 gets officially started and I sadly have to agree with those who normally hold opposite opinions that expectations should be lower.

Even if we get TLD this year, it might be the only great thing we get and the longer they make us wait into 2022 to get it, the more of a let down this coming year is sure to be.